StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3055% below fair value
$1.08−0.02 (-1.82%)

Close on Nov 20, 2026Market cap $4.97MP/E –Yield –

Biomerica free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Biomerica's free cash flow for the twelve months ending May 31, 2024 was -$5.41M. For fiscal 2024 it was -$5.41M. The highest annual figure on record is $1.14M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2024May 31, 2024-$5.41M–
FY2023May 31, 2023-$5.54M–
FY2022May 31, 2022-$536.00K–
FY2021May 31, 2021-$5.39M–
FY2020May 31, 2020-$4.33M–
FY2019May 31, 2019-$2.35M–
FY2018May 31, 2018-$1.30M–
FY2017May 31, 2017-$818.94K–
FY2016May 31, 2016-$300.34K–
FY2015May 31, 2015-$415.98K–
FY2014May 31, 2014-$999.51K-187.9%
FY2013May 31, 2013$1.14M–
FY2012May 31, 2012-$17.39K-109.3%
FY2011May 31, 2011$187.72K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ2 2024May 31, 2024-$1.07M–
Q3 FY2024CQ1 2024Feb 29, 2024-$1.80M–
Q2 FY2024CQ4 2023Nov 30, 2023-$848.00K–
Q1 FY2024CQ3 2023Aug 31, 2023-$1.70M–
Q4 FY2023CQ2 2023May 31, 2023-$963.00K–
Q3 FY2023CQ1 2023Feb 28, 2023-$1.73M-173.8%
Q2 FY2023CQ4 2022Nov 30, 2022-$1.24M-193.0%
Q1 FY2023CQ3 2022Aug 31, 2022-$1.61M-2373.1%
Q4 FY2022CQ2 2022May 31, 2022-$4.28M–
Q3 FY2022CQ1 2022Feb 28, 2022$2.34M–
Q2 FY2022CQ4 2021Nov 30, 2021$1.33M–
Q1 FY2022CQ3 2021Aug 31, 2021$70.70K–
Q4 FY2021CQ2 2021May 31, 2021-$1.04M–
Q3 FY2021CQ1 2021Feb 28, 2021-$1.41M–
Q2 FY2021CQ4 2020Nov 30, 2020-$1.31M–
Q1 FY2021CQ3 2020Aug 31, 2020-$1.64M–
Q4 FY2020CQ2 2020May 31, 2020-$3.50M–
Q3 FY2020CQ1 2020Feb 29, 2020-$458.32K–
Q2 FY2020CQ4 2019Nov 30, 2019-$361.99K–
Q1 FY2020CQ3 2019Aug 31, 2019-$10.33K–
Q4 FY2019CQ2 2019May 31, 2019-$1.01M–
Q3 FY2019CQ1 2019Feb 28, 2019-$276.51K–
Q2 FY2019CQ4 2018Nov 30, 2018-$259.41K–
Q1 FY2019CQ3 2018Aug 31, 2018-$794.74K–
Q4 FY2018CQ2 2018May 31, 2018-$378.09K–
Q3 FY2018CQ1 2018Feb 28, 2018-$510.20K–
Q2 FY2018CQ4 2017Nov 30, 2017-$271.59K–
Q1 FY2018CQ3 2017Aug 31, 2017-$144.69K–
Q4 FY2017CQ2 2017May 31, 2017-$333.73K–
Q3 FY2017CQ1 2017Feb 28, 2017-$151.64K–

More Biomerica figures

See a number that looks wrong?